Glenn Sobotka - Nov 4, 2021 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Accounting Officer
Signature
/s/ Lyn Amor Macaraeg, as Attorney-in-Fact
Stock symbol
AGL
Transactions as of
Nov 4, 2021
Transactions value $
-$2,643,000
Form type
4
Date filed
11/12/2021, 03:17 PM
Next filing
Sep 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $1.14M +150K +4601.23% $7.57 153K Nov 4, 2021 Direct F1
transaction AGL Common Stock Sale -$3.78M -150K -97.87% $25.19 3.26K Nov 4, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Options Exercise $0 -150K -100% $0.00* 0 Nov 4, 2021 Common Stock 150K $7.57 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units.
F2 These options were granted on February 9, 2019, and fully vested on September 14, 2021.